Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Parciante

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|September 12, 2020
Epitranscriptomics in Normal and Malignant HematopoiesisCrescenzio Francesco Minervini, Elisa Parciante, Luciana Impera, et al.
Experimental Hematology & Oncology|December 25, 2021
IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosisCosimo Cumbo, Francesco Tarantini, Luisa Anelli, et al.
Discover Oncology|July 8, 2026
Leukemic architecture as a framework for risk stratification in NPM1-mutated acute myeloid leukemiaFrancesco Tarantini, Luisa Anelli, Antonella Zagaria, et al.
Cancer Genetics|August 27, 2019
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemiaNicoletta Coccaro, Luisa Anelli, Paola Orsini, et al.
International Journal of Molecular Sciences|February 25, 2023
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?Maria Rosa Conserva, Immacolata Redavid, Luisa Anelli, et al.
Leukemia & Lymphoma|July 23, 2024
Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant?Francesco Tarantini, Cosimo Cumbo, Luisa Anelli, et al.
Hematology (Amsterdam, Netherlands)|August 8, 2022
<i>JAK2</i> V617f in chronic myeloid leukemia: driving force or passive bystander?Francesco Tarantini, Cosimo Cumbo, Antonella Zagaria, et al.
Scientific Reports|August 9, 2018
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemiaPaola Orsini, Crescenzio F Minervini, Cosimo Cumbo, et al.
Oncotarget|March 16, 2018
Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patientsCosimo Cumbo, Luciana Impera, Crescenzio Francesco Minervini, et al.
Genes|December 23, 2023
Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal RearrangementsNicoletta Coccaro, Antonella Zagaria, Luisa Anelli, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|September 12, 2020
Epitranscriptomics in Normal and Malignant HematopoiesisCrescenzio Francesco Minervini, Elisa Parciante, Luciana Impera, et al.
Experimental Hematology & Oncology|December 25, 2021
IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosisCosimo Cumbo, Francesco Tarantini, Luisa Anelli, et al.
Discover Oncology|July 8, 2026
Leukemic architecture as a framework for risk stratification in NPM1-mutated acute myeloid leukemiaFrancesco Tarantini, Luisa Anelli, Antonella Zagaria, et al.
Cancer Genetics|August 27, 2019
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemiaNicoletta Coccaro, Luisa Anelli, Paola Orsini, et al.
International Journal of Molecular Sciences|February 25, 2023
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?Maria Rosa Conserva, Immacolata Redavid, Luisa Anelli, et al.
Leukemia & Lymphoma|July 23, 2024
Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant?Francesco Tarantini, Cosimo Cumbo, Luisa Anelli, et al.
Hematology (Amsterdam, Netherlands)|August 8, 2022
<i>JAK2</i> V617f in chronic myeloid leukemia: driving force or passive bystander?Francesco Tarantini, Cosimo Cumbo, Antonella Zagaria, et al.
Scientific Reports|August 9, 2018
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemiaPaola Orsini, Crescenzio F Minervini, Cosimo Cumbo, et al.
Oncotarget|March 16, 2018
Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patientsCosimo Cumbo, Luciana Impera, Crescenzio Francesco Minervini, et al.
Genes|December 23, 2023
Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal RearrangementsNicoletta Coccaro, Antonella Zagaria, Luisa Anelli, et al.
Pageof 4